Cargando…
Applying CiPA paradigm for assessing proarrhythmia risk of Covid-19 current off-label used therapies
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483645/ http://dx.doi.org/10.1016/j.vascn.2021.107042 |
| _version_ | 1784577166669774848 |
|---|---|
| author | Delaunois, Annie Hebeisen, Simon Gryshkova, Vitalina Lushbough, Isabel Passini, Elisa Trovato, Cristian Rodriguez, Blanca Valentin, Jean-Pierre |
| author_facet | Delaunois, Annie Hebeisen, Simon Gryshkova, Vitalina Lushbough, Isabel Passini, Elisa Trovato, Cristian Rodriguez, Blanca Valentin, Jean-Pierre |
| author_sort | Delaunois, Annie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8483645 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84836452021-10-01 Applying CiPA paradigm for assessing proarrhythmia risk of Covid-19 current off-label used therapies Delaunois, Annie Hebeisen, Simon Gryshkova, Vitalina Lushbough, Isabel Passini, Elisa Trovato, Cristian Rodriguez, Blanca Valentin, Jean-Pierre J Pharmacol Toxicol Methods Article Elsevier 2021 2021-09-30 /pmc/articles/PMC8483645/ http://dx.doi.org/10.1016/j.vascn.2021.107042 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Delaunois, Annie Hebeisen, Simon Gryshkova, Vitalina Lushbough, Isabel Passini, Elisa Trovato, Cristian Rodriguez, Blanca Valentin, Jean-Pierre Applying CiPA paradigm for assessing proarrhythmia risk of Covid-19 current off-label used therapies |
| title | Applying CiPA paradigm for assessing proarrhythmia risk of Covid-19 current off-label used therapies |
| title_full | Applying CiPA paradigm for assessing proarrhythmia risk of Covid-19 current off-label used therapies |
| title_fullStr | Applying CiPA paradigm for assessing proarrhythmia risk of Covid-19 current off-label used therapies |
| title_full_unstemmed | Applying CiPA paradigm for assessing proarrhythmia risk of Covid-19 current off-label used therapies |
| title_short | Applying CiPA paradigm for assessing proarrhythmia risk of Covid-19 current off-label used therapies |
| title_sort | applying cipa paradigm for assessing proarrhythmia risk of covid-19 current off-label used therapies |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483645/ http://dx.doi.org/10.1016/j.vascn.2021.107042 |
| work_keys_str_mv | AT delaunoisannie applyingcipaparadigmforassessingproarrhythmiariskofcovid19currentofflabelusedtherapies AT hebeisensimon applyingcipaparadigmforassessingproarrhythmiariskofcovid19currentofflabelusedtherapies AT gryshkovavitalina applyingcipaparadigmforassessingproarrhythmiariskofcovid19currentofflabelusedtherapies AT lushboughisabel applyingcipaparadigmforassessingproarrhythmiariskofcovid19currentofflabelusedtherapies AT passinielisa applyingcipaparadigmforassessingproarrhythmiariskofcovid19currentofflabelusedtherapies AT trovatocristian applyingcipaparadigmforassessingproarrhythmiariskofcovid19currentofflabelusedtherapies AT rodriguezblanca applyingcipaparadigmforassessingproarrhythmiariskofcovid19currentofflabelusedtherapies AT valentinjeanpierre applyingcipaparadigmforassessingproarrhythmiariskofcovid19currentofflabelusedtherapies |